Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Epileptic Disord ; 24(1): 75-81, 2022 Feb 01.
Artigo em Inglês | MEDLINE | ID: mdl-34750097

RESUMO

We aimed to study the ictal EEG patterns in patients with non-convulsive seizures (NCS) and their relationship with underlying etiology and patient outcome. We conducted a retrospective review of EEG studies from patients undergoing continuous EEG (cEEG) monitoring for indication of altered mental status with a suspicion of NCS. Ictal EEG findings of NCS were categorized as three patterns: focal or generalized epileptiform discharges (EDs) at frequencies >2.5 Hz (Pattern 1); EDs at frequencies of ≤2.5 Hz or rhythmic activity >0.5 Hz with spatiotemporal evolution (Pattern 2); and EDs with ≤2.5 Hz with subtle clinical correlate during the ictal EEG or clinical and EEG improvement after a trial of IV anti-seizure drugs (Pattern 3). Patients with anoxic brain injury were excluded from the study. Associations between ictal EEG patterns and underlying etiology and their impact on in-hospital mortality was measured. Of 487 patients included in the study, NCS was recorded on cEEG monitoring in 57 (12%). The ictal EEG Pattern 2 was the most commonly seen ictal EEG finding in our cohort of patients with NCS (70%, n=40/57), followed by Pattern 3 (15%, n=9/57) and Pattern 1(14%, n=8/57). In patients with acute brain injury, Pattern 2 (67%, n=27/40) was a commonly seen ictal EEG finding, whereas Pattern 1 (62% n=5/8) was seen in patients with underlying acute medical illness. No statistically significant difference was found between ictal EEG patterns and underlying neurological versus medical etiologies (p=0.27) or in-hospital mortality (p=0.5). Spatiotemporal evolution of epileptiform discharges at a lower frequency was the most commonly recorded ictal EEG pattern in our cohort. Further prospective studies with a larger sample size of patients with NCS may provide valuable clinical data that could be used to evaluate the etiologic correlate of the various ictal EEG patterns and their effect on outcome.


Assuntos
Convulsões , Eletroencefalografia , Humanos , Prognóstico , Estudos Retrospectivos , Convulsões/etiologia , Convulsões/fisiopatologia
2.
Trop Doct ; 42(2): 94-6, 2012 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-22328602

RESUMO

Our study compares the risk factors, clinical presentations and outcomes of pulmonary infections caused by Nocardia asteroides and non-asteroides species. We performed a retrospective cohort study comparing pulmonary infections by both species in patients presenting to a tertiary care hospital in Karachi, Pakistan. Forty-one patients were identified with pulmonary nocardiosis, with 58.5% belonging to the N. asteroids complex. The most common clinical findings were fever and a cough for both groups, with lobar infiltrates being the most common finding on chest radiographs. In vitro testing showed a sensitivity of all species to trimethoprim-sulfamethoxazole (TMP-SMZ), aminoglycosides, ceftriaxone and imipenem. The majority of the patients were treated with TMP-SMZ in combination with other drugs. The results of our study suggest that there is no significant difference in the risk factors, presentations and outcomes of pulmonary infections by N. asteroides and non-asteroides species. Immunocompromised patients are more likely to have unfavorable outcomes.


Assuntos
Pneumopatias/fisiopatologia , Nocardiose/fisiopatologia , Nocardia asteroides/patogenicidade , Nocardia/patogenicidade , Adulto , Idoso , Antibacterianos/uso terapêutico , Estudos de Coortes , Feminino , Hospitais Universitários/estatística & dados numéricos , Humanos , Hospedeiro Imunocomprometido , Pneumopatias/epidemiologia , Pneumopatias/microbiologia , Pneumopatias/patologia , Masculino , Pessoa de Meia-Idade , Nocardia/classificação , Nocardiose/epidemiologia , Nocardiose/microbiologia , Nocardiose/patologia , Paquistão/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...